BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cox LM, Maghzi AH, Liu S, Tankou SK, Dhang FH, Willocq V, Song A, Wasén C, Tauhid S, Chu R, Anderson MC, De Jager PL, Polgar-Turcsanyi M, Healy BC, Glanz BI, Bakshi R, Chitnis T, Weiner HL. Gut Microbiome in Progressive Multiple Sclerosis. Ann Neurol 2021;89:1195-211. [PMID: 33876477 DOI: 10.1002/ana.26084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 2021;9:226. [PMID: 34784980 DOI: 10.1186/s40168-021-01107-9] [Reference Citation Analysis]
2 Xu R, Zhang Y, Chen S, Zeng Y, Fu X, Chen T, Luo S, Zhang X. The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential. Crit Rev Microbiol 2022;:1-26. [PMID: 35272549 DOI: 10.1080/1040841X.2022.2044286] [Reference Citation Analysis]
3 Amorim Neto DP, Bosque BP, Pereira de Godoy JV, Rodrigues PV, Meneses DD, Tostes K, Costa Tonoli CC, Faustino de Carvalho H, González-billault C, de Castro Fonseca M. Akkermansia muciniphila induces mitochondrial calcium overload and α -synuclein aggregation in an enteroendocrine cell line. iScience 2022;25:103908. [DOI: 10.1016/j.isci.2022.103908] [Reference Citation Analysis]
4 Shobeiri P, Kalantari A, Teixeira AL, Rezaei N. Shedding light on biological sex differences and microbiota-gut-brain axis: a comprehensive review of its roles in neuropsychiatric disorders. Biol Sex Differ 2022;13:12. [PMID: 35337376 DOI: 10.1186/s13293-022-00422-6] [Reference Citation Analysis]
5 Barro C, Paul A, Saleh F, Chitnis T, Weiner HL. Validation of Two Kinetic Assays for the Quantification of Endotoxin in Human Serum. Front Neurol 2021;12:691683. [PMID: 34248828 DOI: 10.3389/fneur.2021.691683] [Reference Citation Analysis]
6 Cerroni R, Pietrucci D, Teofani A, Chillemi G, Liguori C, Pierantozzi M, Unida V, Selmani S, Mercuri NB, Stefani A. Not just a Snapshot: An Italian Longitudinal Evaluation of Stability of Gut Microbiota Findings in Parkinson’s Disease. Brain Sciences 2022;12:739. [DOI: 10.3390/brainsci12060739] [Reference Citation Analysis]
7 El-Hakim Y, Bake S, Mani KK, Sohrabji F. Impact of intestinal disorders on central and peripheral nervous system diseases. Neurobiol Dis 2022;165:105627. [PMID: 35032636 DOI: 10.1016/j.nbd.2022.105627] [Reference Citation Analysis]
8 Al KF, Craven LJ, Gibbons S, Parvathy SN, Wing AC, Graf C, Parham KA, Kerfoot SM, Wilcox H, Burton JP, Kremenchutzky M, Morrow SA, Casserly C, Meddings J, Sharma M, Silverman MS. Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial. Mult Scler J Exp Transl Clin 2022;8:20552173221086662. [PMID: 35571974 DOI: 10.1177/20552173221086662] [Reference Citation Analysis]
9 Ghezzi L, Cantoni C, Pinget GV, Zhou Y, Piccio L. Targeting the gut to treat multiple sclerosis. J Clin Invest 2021;131:143774. [PMID: 34196310 DOI: 10.1172/JCI143774] [Reference Citation Analysis]
10 Nagpal J, Cryan JF. Microbiota-brain interactions: Moving toward mechanisms in model organisms. Neuron 2021:S0896-6273(21)00709-1. [PMID: 34653349 DOI: 10.1016/j.neuron.2021.09.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Barone M, Mendozzi L, D'Amico F, Saresella M, Rampelli S, Piancone F, La Rosa F, Marventano I, Clerici M, d'Arma A, Pugnetti L, Rossi V, Candela M, Brigidi P, Turroni S. Influence of a High-Impact Multidimensional Rehabilitation Program on the Gut Microbiota of Patients with Multiple Sclerosis. Int J Mol Sci 2021;22:7173. [PMID: 34281224 DOI: 10.3390/ijms22137173] [Reference Citation Analysis]
12 Cox LM, Calcagno N, Gauthier C, Madore C, Butovsky O, Weiner HL. The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis. Microbiome 2022;10:47. [PMID: 35272713 DOI: 10.1186/s40168-022-01232-z] [Reference Citation Analysis]
13 Zhu W, Dykstra K, Zhang L, Xia Z. Gut Microbiome as Potential Therapeutics in Multiple Sclerosis. Curr Treat Options Neurol 2021;23. [DOI: 10.1007/s11940-021-00693-1] [Reference Citation Analysis]
14 Bierhansl L, Hartung HP, Aktas O, Ruck T, Roden M, Meuth SG. Thinking outside the box: non-canonical targets in multiple sclerosis. Nat Rev Drug Discov 2022. [PMID: 35668103 DOI: 10.1038/s41573-022-00477-5] [Reference Citation Analysis]
15 Zangeneh Z, Abdi-Ali A, Khamooshian K, Alvandi A, Abiri R. Bacterial variation in the oral microbiota in multiple sclerosis patients. PLoS One 2021;16:e0260384. [PMID: 34847159 DOI: 10.1371/journal.pone.0260384] [Reference Citation Analysis]
16 Wan X, Eguchi A, Qu Y, Yang Y, Chang L, Shan J, Mori C, Hashimoto K. Gut-microbiota-brain axis in the vulnerability to psychosis in adulthood after repeated cannabis exposure during adolescence. Eur Arch Psychiatry Clin Neurosci 2022. [PMID: 35666299 DOI: 10.1007/s00406-022-01437-1] [Reference Citation Analysis]
17 Mechelli R, Romano S, Romano C, Morena E, Buscarinu MC, Bigi R, Bellucci G, Reniè R, Pellicciari G, Salvetti M, Ristori G. MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases. Microorganisms 2021;9:1132. [PMID: 34074025 DOI: 10.3390/microorganisms9061132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]